Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Car... Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solutions, rhythm management, surgery, coronary and renal denervation, mechanical circulatory support, peripheral vascular health, structural heart and aortic products; Diabetes, offering therapies and services for insulin-dependent individuals with Type 1 and Type 2 diabetes; Medical Surgical, encompassing surgical endoscopy and acute care and monitoring; and Restorative Therapies, covering cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. Medtronic plc produces innovative products such as implantable pacemakers, cardioverter-defibrillators, spinal cord stimulators, insulin pumps, and remote monitoring systems, serving patients in hospitals, homes, and surgical settings worldwide. Founded in 1949 and legally headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, it focuses on advancing healthcare through minimally invasive therapies, disease management, and patient monitoring technologies in more than 150 countries.
Based on current regulatory requirements, Medtronic is not required to report EU
Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU
Taxonomy data review for this company.
If you believe this assessment should be revisited, you may submit a data coverage request
and our team will review the company's regulatory applicability.
Account Restricted
Your account has been restricted and you no longer have access to paid features.
Contact our support team
or
upgrade your plan
to unblock your account.